Expression of Development-Phase Specific Alkaline Phosphatase Isoenzymes in Cultured Cancer Cells

  • W. H. Fishman


The history of the demonstration of development-phase specific alkaline phosphatase (AP) isoenzymes goes back to 1976 when Lillian Fishman and her colleagues (1) reported their observations on placental AP. They found that the microvilli of placenta earlier than 10 weeks produced a different alkaline phosphatase than the one which characterized the second and third trimester placentas. The early placental alkaline phosphatase is heat-sensitive, inhibited by L-homoarginine, not L-phênylalanine, and migrates on electrophoresis faster than the term isoenzyme. The latter is very heat stable, inhibited by L-phenylalanine but not L-homoarginine, and is represented by a myriad of electrophoretic variants and distinctive immunologic determinants. Interestingly, the two isoenzymes overlapped in their expression between 10 and 12 weeks of pregnancy and both have the very same syncitiotropho-blast location.


Cervical Cancer Alkaline Phosphatase Sodium Butyrate Culture Cancer Cell Placental Alkaline Phosphatase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1).
    FISHMAN, L., MIYAYAMA, H., DRISCOLL, S.G. and FISHMAN, W.H. (1976). Developmental phase-specific alkaline phosphatase isoenzymes of human placental and their occurrence in human cancer. Cancer Res., 36, 2268.PubMedGoogle Scholar
  2. 2).
    SASAKI, M. and FISHMAN, W.H. (1973). Ultrastructural studies on Regan and non-Regan isoenzymes of alkaline phosphatase in human ovarian cancer cells. Cancer Res., 33, 3008.PubMedGoogle Scholar
  3. 3).
    SINGER, R.M. and FISHMAN, W.H. (1974). Characterization of two HeLa sublines: TCRC-1 produces Regan isoenzyme and TCRC-2, non Regan-isoenzyme. J. Cell Biol., 60, 777.PubMedCrossRefGoogle Scholar
  4. 4).
    HIGASHINO, K., KUDO, S., OTANI, R., YAMAMURA, Y., HONDA, T. and SAKURAI, J. (1975). A hepatoma-associated alkaline phosphatase, the Kasahara isoenzyme, compared with one of the isoenzymes of FL amnion cells. An. N. Y. Acad. Sci., 259, 337.CrossRefGoogle Scholar
  5. 5).
    STIGBRand, T., MILLAN, J. and FISHMAN, W.H. (1982). The genetic basis of alkaline phosphatase isoenzyme expression. In: Isozymes CTMBR (ed. M.C. Rattazzi), Vol. 6, Alan R. Liss, Inc., New York.Google Scholar
  6. 6).
    TOKUMITSU, S., TOKUMITSU, K. and FISHMAN, W.H. (1981). Immuno-cytochemical demonstration of intracytoplasmic alkaline phosphatase in HeLa TCRC-1 cells. J. Hi stochern, and Cytochem., 29, 1080.CrossRefGoogle Scholar
  7. 7).
    TOKUMITSU, S., TOKUMITSU, K. and FISHMAN, W.H. (1981). Intracellular alkaline phosphatase activity in cultured human cancer cells. Histochemistry, 73, 1.PubMedCrossRefGoogle Scholar
  8. 8).
    Kottel, R.H. and Hanford, W.C. (1980). Differential release of membrane-bound alkaline phosphatase isoenzymes from tumour cells by bromelain. J. Biochem. Biophys, Methods, 2, 325.CrossRefGoogle Scholar
  9. 9).
    HANFORD, W.C. and FISHMAN, W.H. (1982). unpublished observations.Google Scholar
  10. 10).
    MILLAN, J.L., STIGBRand, T., RUOSLAHTI, E. and FISHMAN, W.H. (1982). An allotype-specific monoclonal antibody to placental alkaline phosphatase; its characterization and use in the study of cancer related phosphatase polymorphism. Cancer Res., 42, 2444.PubMedGoogle Scholar
  11. 11).
    JEMMERSON, R. and FISHMAN, W.H. (1982). Convenient selection of monoclonal antibodies to isoenzymes of placental alkaline phosphatase using the antigens catalytic activity in enzyme antigen immunoassay (EAIA). Analytical Biochemistry, in press.Google Scholar
  12. 12).
    SINGER, R.M. and FISHMAN, W.H. (1975). Specific isozyme profiles of alkaline phosphatase in prednisolone-treated human cell populations, In: Isoenzymes III: Developmental Biology, Academic Press, Inc., New York, p. 753.Google Scholar
  13. 13).
    TAKEYA, M., TOKUMITSU, S. and KOHNOE, K. (1980). Application of the enzyme histochemical method for the isolation of a HeLa variant inducibly producing the Kasahara isoenzyme of alkaline phosphatase. Gann., 71, 710.PubMedGoogle Scholar
  14. 14).
    KOTTEL, R.H. and FISHMAN, W.H. (1981). Placental alkaline phosphatase isoenzyme expression by the non-HeLa cervical carcinoma cell line. Biochem. J., 200, 461.PubMedGoogle Scholar
  15. 15).
    KOTTEL, R.H. and FISHMAN, W.H. (1978). Modulation of HeLa cell alkaline phosphatase isoenzyme expression by prednisolone In: Carcinoembryonic Proteins (eds, B. Norgaard-Pedersen and N.H. Axelson), p. 571, Blackwell Scientific Publ., Oxford.Google Scholar
  16. 16).
    KOHNOE, K., TOKUMITSU, S. and TAKEYA, M. (1980). Alkaline phosphatase from two HeLa S3 subclones: one producing Regan and the other Kasahara Isoenzyme. Oncodevelop. Biol, and Med., 1, 199.Google Scholar
  17. 17).
    TOKUMITSU, S-I., TOKUMITSU, K., KOHNOE, K. and TAKEUCHI, T. (1979). Characterization of liver-type alkaline phosphatase from human gastric carcinoma cells (KMK-2) in vitro. Cancer Res., 39, 4732.PubMedGoogle Scholar
  18. 18).
    NOZAWA, S., UDAGAWA, Y., OOTA, H., KURIHARA, S. and FISHMAN, W.H. (1982). A newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin β-subunit and pregnancy-specific β1, glycoprotein phenotypes. Cancer Res., in press.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • W. H. Fishman
    • 1
  1. 1.La Jolla Cancer Research FoundationCancer Research CenterLa JollaUSA

Personalised recommendations